Prognostic factors in breast cancer patients following neoadjuvant chemotherapy

被引：0
|
作者：
Kim, JR [1 ]
Chang, ES [1 ]
机构：
[1] Chungnam Natl Univ, Dept Surg, Taejon 305764, South Korea
来源：
BIOMEDICINE & PHARMACOTHERAPY | 2005年 / 59卷
关键词：
breast cancer; neoadjuvant chemotherapy; axillary lymph node;
D O I：
10.1016/S0753-3322(05)80093-9
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：S395 / S396
页数：2
相关论文
共 50 条
  • [21] Prognostic Factors in HER2-Positive Primary Breast Cancer Patients Treated Using Neoadjuvant Chemotherapy Plus Trastuzumab
    Fujita, Noriko
    Enomoto, Yukie
    Inakami, Keiko
    Yanagisawa, Tetsu
    Iguchi, Chikage
    Aono, Toyokazu
    Nomura, Takashi
    Yamamoto, Hitoshi
    Kasugai, Tsutomu
    Shiba, Eiichi
    ONCOLOGY, 2020, 98 (01) : 35 - 41
  • [22] Predictive and Prognostic Value of Inflammatory and Nutritional Indexes in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy
    Arici, Mustafa Ozgur
    Salim, Derya Kivrak
    Kocer, Murat
    Alparslan, Ahmet Sukru
    Karakas, Baris Rafet
    Ozturk, Banu
    MEDICINA-LITHUANIA, 2024, 60 (11):
  • [23] Predictive and prognostic value of EPIC1 in patients with breast cancer receiving neoadjuvant chemotherapy
    Xu, Yaqian
    Wang, Yan
    Yuan, Chenwei
    Sheng, Xiaonan
    Sha, Rui
    Dai, Huijuan
    Zhang, Shan
    Wang, Yaohui
    Lin, Yanping
    Zhou, Liheng
    Xu, Shuguang
    Zhang, Jie
    Yin, Wenjin
    Lu, Jinsong
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [24] Neoadjuvant chemotherapy in patients with breast cancer
    Jakesz, R
    Taucher, S
    Gnant, M
    Gebhard, B
    Kandioler, D
    Rudas, M
    Djavanmard, M
    Steger, G
    ZENTRALBLATT FUR CHIRURGIE, 1998, 123 : 147 - 150
  • [25] Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer
    Pierga, JY
    Mouret, E
    Diéras, V
    Laurence, V
    Beuzeboc, P
    Dorval, T
    Palangié, T
    Jouve, M
    Vincent-Salomon, A
    Scholl, S
    Extra, JM
    Asselain, B
    Pouillart, P
    BRITISH JOURNAL OF CANCER, 2000, 83 (11) : 1480 - 1487
  • [26] Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer
    J-Y Pierga
    E Mouret
    V Diéras
    V Laurence
    P Beuzeboc
    T Dorval
    T Palangié
    M Jouve
    A Vincent-Salomon
    S Scholl
    J-M Extra
    B Asselain
    P Pouillart
    British Journal of Cancer, 2000, 83 : 1480 - 1487
  • [27] LOCOREGIONAL RECURRENCE OF BREAST CANCER IN PATIENTS TREATED WITH BREAST CONSERVATION SURGERY AND RADIOTHERAPY FOLLOWING NEOADJUVANT CHEMOTHERAPY
    Min, Sun Young
    Lee, Seung Ju
    Shin, Kyung Hwan
    Park, In Hae
    Jung, So-Youn
    Lee, Keun Seok
    Ro, Jungsil
    Lee, Seeyoun
    Kim, Seok Won
    Kim, Tae Hyun
    Kang, Han-Sung
    Cho, Kwan Ho
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : E697 - E705
  • [28] Anemia and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
    Danzinger, Sabine
    Fuegerl, Alexandra
    Pfeifer, Christian
    Bernathova, Maria
    Tendl-Schulz, Kristina
    Seifert, Michael
    CANCER INVESTIGATION, 2021, 39 (6-7) : 457 - 465
  • [29] Predictive factors of response to anthracylines neoadjuvant chemotherapy in breast cancer
    Bensouda, Y.
    Ismaili, N.
    Ahbeddou, N.
    El Hassani, K.
    Chenna, M.
    Sbitti, Y.
    Boutayeb, S.
    Errihani, H.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2011, 39 (02): : 81 - 86
  • [30] Clinical significance and prognostic value of receptor conversion after neoadjuvant chemotherapy in breast cancer patients
    He, Yang
    Zhang, Jing
    Chen, Hui
    Zhou, Ying
    Hong, Liping
    Ma, Yue
    Chen, Nannan
    Zhao, Weipeng
    Tong, Zhongsheng
    FRONTIERS IN SURGERY, 2023, 9
12345